Iron Deficiency Anemia in Twin Pregnancies

July 22, 2021 updated by: Caixia Liu, Shengjing Hospital

Prospective Study of Iron Deficiency Anemia in Twin Pregnancy

All pregnant women with twin pregnancies were given oral iron according to the current recommended dose. Blood routine and ferritin were monitored during pregnancy to understand the therapeutic effect of oral iron on iron deficiency anemia and iron deficiency in pregnant women with twin pregnancies

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

All pregnant women with twin pregnancies were given oral iron according to the current recommended dose. Blood routine and ferritin were monitored every 2-4 weeks during pregnancy to understand the therapeutic effect of oral iron on iron deficiency anemia and iron deficiency in pregnant women with twin pregnancies.After delivery, we will test the neonatal ferritin and hemoglobin status. Our aim was to investigate the effects of iron supplementation during twin pregnancy on maternal and neonatal ferritin and anemia.

Study Type

Interventional

Enrollment (Anticipated)

1000

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 50 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Chinese
  • Pregnant women with twin pregnancies

Exclusion Criteria:

  • Single pregnancy
  • Types of anemia other than iron deficiency anemia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Anemia Correction Group
Continue to take the current medication orally at the current dose
Drug: Iron
One of each type of iron was taken orally according to the instructions and followed every two weeks
Other Names:
  • ferrous succinate
  • ferrous sulfate
  • polyferose
  • Chinese medicine filling iron agent
Experimental: Anemia uncorrected group
Continue to take the current medication orally at the current dose
Drug: Iron
One of each type of iron was taken orally according to the instructions and followed every two weeks
Other Names:
  • ferrous succinate
  • ferrous sulfate
  • polyferose
  • Chinese medicine filling iron agent

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Routine blood
Time Frame: 2-4 weeks after antenatal care
Routine blood and serum ferritin（ng/ml）were checked 2-4 weeks
2-4 weeks after antenatal care

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
serum ferritin
Time Frame: 2-4 weeks after antenatal care
routine blood and serum ferritin（ng/ml）were checked 2-4 weeks
2-4 weeks after antenatal care

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Shengjing Hospital

Investigators

  • Study Chair: Caixia Liu, Shengjing Hospital of CMU

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

July 15, 2021

Primary Completion (Anticipated)

December 1, 2021

Study Completion (Anticipated)

July 1, 2022

Study Registration Dates

First Submitted

June 21, 2021

First Submitted That Met QC Criteria

July 22, 2021

First Posted (Actual)

July 23, 2021

Study Record Updates

Last Update Posted (Actual)

July 23, 2021

Last Update Submitted That Met QC Criteria

July 22, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IDA in TP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anemia, Iron-Deficiency

Clinical Trials on Iron

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe